Do Aurora Innovation Inc (NASDAQ: AUR) Fit In A Value Investing Philosophy?

Currently, there are 1.41B common shares owned by the public and among those 979.68M shares have been available to trade.

The company’s stock has a 5-day price change of -8.26% and -26.89% over the past three months. AUR shares are trading 112.20% year to date (YTD), with the 12-month market performance down to -17.14% lower. It has a 12-month low price of $2.17 and touched a high of $10.77 over the same period. AUR has an average intraday trading volume of 20.05 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -9.84%, -18.29%, and -18.82% respectively.

Institutional ownership of Aurora Innovation Inc (NASDAQ: AUR) shares accounts for 54.58% of the company’s 1.41B shares outstanding.

It has a market capitalization of $9.23B and a beta (3y monthly) value of 2.60. The earnings-per-share (ttm) stands at -$0.47. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.28% over the week and 2.35% over the month.

Analysts forecast that Aurora Innovation Inc (AUR) will achieve an EPS of -0.12 for the current quarter, -0.12 for the next quarter and -0.49 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.12 while analysts give the company a high EPS estimate of -0.12. Comparatively, EPS for the current quarter was -0.09 a year ago. Earnings per share for the fiscal year are expected to decrease by -3.52%, and 4.71% over the next financial year. EPS should grow at an annualized rate of 5.41% over the next five years, compared to -24.76% over the past 5-year period.

Looking at the support for the AUR, a number of firms have released research notes about the stock. Needham stated their Buy rating for the stock in a research note on April 15, 2025, with the firm’s price target at $10. Goldman coverage for the Aurora Innovation Inc (AUR) stock in a research note released on April 10, 2025 offered a Neutral rating with a price target of $6. Oppenheimer was of a view on March 27, 2025 that the stock is Outperform, while TD Cowen gave the stock Hold rating on March 07, 2025, issuing a price target of $8. Morgan Stanley on their part issued Overweight rating on March 03, 2025.

Related Posts

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.